A total of 18 vouchers have been issued via the framework despite a lack of clarity on the awarding process.
OPKO Health is refocusing on drug development, with most pipeline assets in early stages and limited near-term catalysts. Learn why OPK stock is a Hold.
Q4 2025 earnings call recap: record sales, Germany turnaround, DrugSorb-ATR FDA progress, and breakeven target.
Draft guidance, issued by the FDA last week, could remove ambiguity and uncertainty that may have so far limited uptake of ...
Accelerated approval of semaglutide 7.2 mg establishes a higher-dose, once-weekly GLP-1 RA option for long-term weight ...
Submitted GraftAssureDx™ for kidney transplant rejection testing for FDA review on Wednesday, March 25Welcomed second ...
By Ahmed Aboulenein WASHINGTON, March 25 (Reuters) - U.S. Senate Republicans launched an investigation into abortion pill manufacturers on Wednesday and called on the U.S. Food and Drug Administration ...
Legal marijuana use doesn’t always protect job candidates. Learn how state and local laws shape THC testing, hiring decisions, and employer risk.
A Massachusetts woman with early onset Alzheimer's fought her insurer over a denied treatment, raising questions about age ...
Certuma launched out of stealth with $10 million in funding from 8VC and a grand plan to make AI smart enough — and safe ...
Adstiladrin may now be thawed in a water bath following an FDA label update, facilitating more efficient treatment delivery for bladder cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results